Malik Nasir Baz, MD
Allergy · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Baz’s office at (559) 436-4500 to ask if they take your plan before you enroll.
California Medical Board record
Licence A35393 · Current
Licensed to practise in California · since 1980 · expires 2028-03-31 · University of the Punjab, King Edward Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$1,795
Medicare paid this office $1,795 for 99 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Professional service for multiple injections of allergen | 95 | $286 | $2 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax by washing | 21 | – | 13 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
99 Original Medicare patients in 2024. Average age 71 · Women 55% · Also on Medicaid 24% · Health risk score 0.98. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 1.
Conditions among them: High blood pressure 75% · Diabetes 37% · Coronary heart disease 31% · Chronic kidney disease 21% · COPD 16% · Depression 13%.
The office billed $8,020, Medicare allowed $4,329 and paid $1,795; for 286 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 99 | 286 | 71 | 0.98 | $8,020 | $1,795 |
| 2023 | 224 | 13,058 | 70 | 0.90 | $328,015 | $149,462 |
| 2022 | 529 | 20,291 | 71 | 0.92 | $627,893 | $319,124 |
| 2021 | 1,053 | 27,927 | 71 | 0.90 | $886,338 | $473,218 |
| 2020 | 730 | 17,975 | 70 | 0.96 | $484,773 | $211,449 |
| 2019 | 754 | 26,010 | 70 | 1.03 | $656,519 | $298,077 |
| 2018 | 838 | 24,899 | 69 | 1.00 | $641,432 | $264,952 |
| 2017 | 865 | 23,974 | 69 | 1.00 | $619,819 | $266,229 |
| 2016 | 483 | 11,235 | 68 | 0.95 | $283,370 | $122,849 |
| 2015 | 357 | 9,544 | 68 | 0.91 | $224,566 | $94,177 |
| 2014 | 435 | 11,884 | 68 | 0.95 | $329,395 | $134,993 |
| 2013 | 597 | 19,298 | 68 | 1.00 | $483,987 | $219,588 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Professional service for preparation and provision of 1 or more antigens | 155 | $105,718 | $12 |
| Professional service for multiple injections of allergen | 193 | $36,372 | $9 |
| Return visit (30+ min) | 15 | $1,594 | $100 |
| Short return visit (20+ min) | 12 | $974 | $70 |
| Test to measure expiratory airflow and volume | 14 | $298 | $21 |
2022: 18 services
| Professional service for preparation and provision of 1 or more antigens | 195 | $144,015 | $13 |
| Professional service for multiple injections of allergen | 261 | $47,501 | $9 |
| Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 107 | $39,257 | $367 |
| New patient visit (45+ min) | 153 | $17,684 | $116 |
| Short return visit (20+ min) | 76 | $13,586 | $72 |
| Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 25 | $12,062 | $482 |
| Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 21 | $10,127 | $482 |
| Return visit (30+ min) | 70 | $8,719 | $101 |
| Test for allergy using allergenic extract | 28 | $7,084 | $3 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 157 | $5,555 | $35 |
| Test to measure expiratory airflow and volume | 71 | $2,680 | $22 |
| Test for allergy using allergenic extract injected into skin | 18 | $2,344 | $7 |
| New patient visit (30+ min) | 15 | $916 | $61 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 13 | $439 | $34 |
| Evaluation of use of breathing device | 25 | $413 | $14 |
| Inhalation treatment for airway obstruction or sputum production | 19 | $184 | $10 |
| Infusion, normal saline solution, 250 cc | 104 | $51 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 19 | $1 | None |
2021: 19 services
| Professional service for preparation and provision of 1 or more antigens | 233 | $162,970 | $13 |
| Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 132 | $61,287 | $464 |
| Professional service for multiple injections of allergen | 375 | $59,935 | $9 |
| Short return visit (20+ min) | 427 | $43,507 | $67 |
| New patient visit (45+ min) | 145 | $19,080 | $132 |
| Return visit (30+ min) | 109 | $14,627 | $101 |
| Test for allergy using allergenic extract | 43 | $11,496 | $3 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose | 254 | $9,851 | $39 |
| New patient visit (30+ min) | 133 | $7,741 | $58 |
| Test to measure expiratory airflow and volume | 203 | $6,335 | $23 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose | 222 | $5,400 | $24 |
| Test for allergy using allergenic extract injected into skin | 30 | $5,241 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 26 | $1,031 | $40 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 19 | $671 | $35 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, booster dose | 15 | $628 | $42 |
| Evaluation of use of breathing device | 17 | $433 | $14 |
| Inhalation treatment for airway obstruction or sputum production | 30 | $410 | $12 |
| Removal of impacted ear wax by washing | 12 | $214 | $16 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 32 | $3 | None |
2020: 14 services
| Professional service for preparation and provision of 1 or more antigens | 179 | $94,985 | $12 |
| Professional service for multiple injections of allergen | 353 | $43,755 | $8 |
| Short return visit (20+ min) | 347 | $22,347 | $51 |
| Return visit (30+ min) | 129 | $11,727 | $78 |
| Test for allergy using allergenic extract | 31 | $8,692 | $4 |
| Test to measure expiratory airflow and volume | 204 | $6,943 | $27 |
| New patient visit (45+ min) | 33 | $3,436 | $104 |
| Test for allergy using allergenic extract injected into skin | 15 | $2,518 | $7 |
| New patient visit (30+ min) | 32 | $1,813 | $57 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 32 | $1,499 | $47 |
| Professional service for single injection of allergen | 12 | $1,220 | $7 |
| Evaluation of use of breathing device | 58 | $818 | $13 |
| Inhalation treatment for airway obstruction or sputum production | 32 | $488 | $15 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 38 | $2 | None |
2019: 16 services
| Professional service for preparation and provision of 1 or more antigens | 246 | $123,839 | $12 |
| Professional service for multiple injections of allergen | 317 | $59,376 | $8 |
| Short return visit (20+ min) | 436 | $43,937 | $57 |
| Test for allergy using allergenic extract | 62 | $17,006 | $3 |
| Return visit (30+ min) | 129 | $13,676 | $84 |
| Test to measure expiratory airflow and volume | 277 | $12,412 | $29 |
| New patient visit (45+ min) | 75 | $9,045 | $121 |
| Test for allergy using allergenic extract injected into skin | 32 | $5,025 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 60 | $2,995 | $50 |
| Evaluation of use of breathing device | 108 | $1,994 | $15 |
| New patient visit (30+ min) | 19 | $1,543 | $81 |
| Inhalation treatment for airway obstruction or sputum production | 92 | $1,466 | $15 |
| Professional service for single injection of allergen | 15 | $1,434 | $7 |
| Test to measure largest amount of air breathed in an out | 11 | $352 | $10 |
| Removal of impacted ear wax by washing | 21 | $250 | $12 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 94 | $7 | None |
2018: 19 services
| Professional service for preparation and provision of 1 or more antigens | 250 | $93,030 | $10 |
| Professional service for multiple injections of allergen | 348 | $50,842 | $8 |
| Short return visit (20+ min) | 433 | $39,467 | $52 |
| Test for allergy using allergenic extract | 68 | $22,845 | $4 |
| Return visit (30+ min) | 190 | $17,841 | $77 |
| Test to measure expiratory airflow and volume | 270 | $12,067 | $28 |
| New patient visit (45+ min) | 87 | $8,514 | $98 |
| Test for allergy using allergenic extract injected into skin | 32 | $4,573 | $6 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 82 | $3,748 | $45 |
| Inhalation treatment for airway obstruction or sputum production | 117 | $1,842 | $14 |
| New patient visit (30+ min) | 25 | $1,550 | $62 |
| Professional service for single injection of allergen | 11 | $1,318 | $7 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $750 | $12 |
| Test to measure the level of nitric oxide gas | 34 | $707 | $16 |
| Removal of impacted ear wax | 17 | $651 | $38 |
| Evaluation of use of breathing device | 41 | $635 | $13 |
| Test to measure largest amount of air breathed in an out | 12 | $338 | $8 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 93 | $19 | None |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 31 | $1 | None |
2017: 14 services
| Professional service for preparation and provision of 1 or more antigens | 235 | $88,660 | $10 |
| Professional service for multiple injections of allergen | 334 | $47,453 | $8 |
| Short return visit (20+ min) | 460 | $42,496 | $53 |
| Test for allergy using allergenic extract | 84 | $30,888 | $5 |
| Return visit (30+ min) | 177 | $16,848 | $81 |
| New patient visit (45+ min) | 113 | $12,832 | $114 |
| Test to measure expiratory airflow and volume | 306 | $11,094 | $27 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 80 | $3,858 | $48 |
| New patient visit (30+ min) | 44 | $3,281 | $75 |
| Test for allergy using allergenic extract injected into skin | 18 | $2,007 | $6 |
| Inhalation treatment for airway obstruction or sputum production | 96 | $1,532 | $15 |
| Removal of impacted ear wax | 13 | $474 | $36 |
| Evaluation of use of breathing device | 36 | $472 | $13 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 97 | $24 | None |
2016: 13 services
| Professional service for preparation and provision of 1 or more antigens | 166 | $54,477 | $10 |
| Professional service for multiple injections of allergen | 269 | $28,933 | $8 |
| Short return visit (20+ min) | 222 | $16,472 | $58 |
| Test for allergy using allergenic extract | 17 | $7,649 | $6 |
| Return visit (30+ min) | 41 | $3,912 | $83 |
| Test to measure expiratory airflow and volume | 111 | $3,617 | $29 |
| New patient visit (45+ min) | 17 | $2,243 | $132 |
| Test for allergy using allergenic extract injected into skin | 13 | $1,631 | $6 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 16 | $860 | $51 |
| Inhalation treatment for airway obstruction or sputum production | 21 | $323 | $15 |
| Test to measure largest amount of air breathed in an out | 14 | $283 | $18 |
| Evaluation of use of breathing device | 11 | $174 | $14 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 23 | $6 | None |
2015: 11 services
| Professional service for preparation and provision of 1 or more antigens | 109 | $41,679 | $10 |
| Professional service for multiple injections of allergen | 187 | $19,249 | $7 |
| Short return visit (20+ min) | 159 | $11,087 | $53 |
| Test for allergy using allergenic extract | 25 | $10,794 | $5 |
| Test to measure expiratory airflow and volume | 80 | $2,524 | $28 |
| New patient visit (30+ min) | 23 | $1,660 | $72 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 49 | $1,058 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $762 | $51 |
| Inhalation treatment for airway obstruction or sputum production | 18 | $278 | $15 |
| Evaluation of use of breathing device | 13 | $203 | $15 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 18 | $5 | None |
2014: 16 services
| Professional service for preparation and provision of 1 or more antigens | 130 | $48,464 | $10 |
| Professional service for multiple injections of allergen | 233 | $27,520 | $8 |
| Short return visit (20+ min) | 220 | $15,760 | $51 |
| Test for allergy using allergenic extract | 23 | $9,647 | $5 |
| Return visit (30+ min) | 88 | $8,149 | $75 |
| Test to measure expiratory airflow and volume | 131 | $4,465 | $26 |
| New patient visit (45+ min) | 38 | $4,436 | $117 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 94 | $3,632 | $14 |
| Ct scan of face without contrast | 19 | $3,123 | $149 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 47 | $2,919 | $50 |
| Test to measure largest amount of air breathed in an out | 71 | $1,884 | $19 |
| Test for allergy using allergenic extract injected into skin | 12 | $1,669 | $6 |
| Inhalation treatment for airway obstruction or sputum production | 52 | $986 | $15 |
| Test to measure the level of nitric oxide gas | 31 | $587 | $16 |
| Evaluation of use of breathing device | 20 | $321 | $13 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 50 | $17 | None |
2013: 15 services
| Professional service for preparation and provision of 1 or more antigens | 173 | $61,400 | $10 |
| Professional service for multiple injections of allergen | 275 | $37,552 | $8 |
| Test for allergy using allergenic extract | 72 | $32,451 | $6 |
| Short return visit (20+ min) | 325 | $27,467 | $55 |
| Return visit (30+ min) | 167 | $16,462 | $81 |
| New patient visit (45+ min) | 71 | $9,017 | $127 |
| Test to measure expiratory airflow and volume | 212 | $8,144 | $30 |
| Test for allergy using allergenic extract injected into skin | 47 | $7,147 | $7 |
| Ct scan of face without contrast | 29 | $5,581 | $192 |
| Test to measure largest amount of air breathed in an out | 134 | $4,113 | $18 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 64 | $3,676 | $53 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $1,768 | $16 |
| Inhalation treatment for airway obstruction or sputum production | 70 | $1,245 | $16 |
| Evaluation of use of breathing device | 57 | $922 | $15 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 47 | $12 | None |
Medicaid work
$775,711 in 2024
Medicaid paid $775,711 for 21,558 billed services this clinician did in 2024, up to 261 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| ANTIGEN THERAPY SERVICES | 3,562 | $240,701 |
| OFF/OP EST MAY X REQ PHY/QHP | 4,034 | $95,076 |
| Maximum breathing capacity, maximal voluntary ventilation | 5,420 | $90,959 |
| Return visit (30+ min) | 731 | $90,922 |
| Short return visit (20+ min) | 1,073 | $87,345 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 5,276 | $64,857 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 230 | $51,230 |
| New patient visit (45+ min) | 174 | $28,932 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 719 | $19,724 |
| Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device | 323 | $5,965 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 16 | $0 |
| 2024 | 21,558 | 11 | 261 | $775,711 |
| 2023 | 24,740 | 7 | 115 | $477,416 |
| 2022 | 31,330 | 14 | 100 | $714,669 |
| 2021 | 51,484 | 18 | 165 | $1,073,488 |
| 2020 | 42,678 | 18 | 152 | $985,403 |
| 2019 | 56,991 | 16 | 226 | $1,352,664 |
| 2018 | 78,424 | 17 | 231 | $2,534,830 |
See the largest Medicaid services in earlier years
2023
| ANTIGEN THERAPY SERVICES | 2,159 | $164,418 |
| Maximum breathing capacity, maximal voluntary ventilation | 6,586 | $102,169 |
| OFF/OP EST MAY X REQ PHY/QHP | 4,650 | $78,425 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 10,403 | $62,568 |
| Short return visit (20+ min) | 618 | $46,890 |
| New patient visit (45+ min) | 99 | $16,662 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 225 | $6,285 |
2022
| ANTIGEN THERAPY SERVICES | 3,210 | $234,461 |
| Maximum breathing capacity, maximal voluntary ventilation | 7,948 | $132,059 |
| OFF/OP EST MAY X REQ PHY/QHP | 7,462 | $129,906 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 10,967 | $74,338 |
| Short return visit (20+ min) | 788 | $58,006 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 153 | $42,559 |
| Return visit (30+ min) | 269 | $21,576 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 272 | $6,826 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 44 | $5,462 |
| Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 48 | $5,378 |
| New patient visit (45+ min) | 16 | $2,599 |
| EVALUATION OF WHEEZING | 29 | $1,175 |
2021
| ANTIGEN THERAPY SERVICES | 4,082 | $352,041 |
| Maximum breathing capacity, maximal voluntary ventilation | 12,382 | $182,914 |
| OFF/OP EST MAY X REQ PHY/QHP | 11,352 | $166,649 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 15,959 | $96,200 |
| Short return visit (20+ min) | 2,129 | $77,629 |
| Return visit (30+ min) | 935 | $76,338 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 358 | $57,866 |
| New patient visit (45+ min) | 276 | $30,301 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 1,000 | $17,982 |
| EVALUATION OF WHEEZING | 62 | $3,571 |
| Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 27 | $3,471 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; second dose | 85 | $3,285 |
2020
| ANTIGEN THERAPY SERVICES | 3,483 | $295,287 |
| Maximum breathing capacity, maximal voluntary ventilation | 11,027 | $200,348 |
| OFF/OP EST MAY X REQ PHY/QHP | 8,589 | $138,820 |
| Short return visit (20+ min) | 2,826 | $115,416 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 13,864 | $85,471 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 217 | $54,176 |
| Return visit (30+ min) | 608 | $50,405 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 910 | $26,708 |
| New patient visit (45+ min) | 108 | $11,639 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 12 | $2,312 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 13 | $1,693 |
| New patient visit (30+ min) | 16 | $1,640 |
2019
| Maximum breathing capacity, maximal voluntary ventilation | 16,251 | $270,647 |
| ANTIGEN THERAPY SERVICES | 5,022 | $243,324 |
| Short return visit (20+ min) | 4,038 | $207,431 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 489 | $193,856 |
| OFF/OP EST MAY X REQ PHY/QHP | 11,342 | $172,614 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 16,199 | $110,913 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 258 | $33,205 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 1,036 | $30,192 |
| Return visit (30+ min) | 238 | $24,223 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 116 | $21,178 |
| EVALUATION OF WHEEZING | 266 | $16,848 |
| Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device | 863 | $10,009 |
2018
| ANTIGEN THERAPY SERVICES | 7,813 | $585,558 |
| Maximum breathing capacity, maximal voluntary ventilation | 21,746 | $412,722 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 1,216 | $406,231 |
| Short return visit (20+ min) | 5,478 | $306,412 |
| OFF/OP EST MAY X REQ PHY/QHP | 16,368 | $296,900 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 20,432 | $164,098 |
| Return visit (30+ min) | 1,573 | $140,097 |
| New patient visit (45+ min) | 404 | $47,171 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 380 | $45,375 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 227 | $42,582 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 1,227 | $36,536 |
| EVALUATION OF WHEEZING | 401 | $25,424 |
Drugs they prescribed that Part D paid
$11,200
Pharmacies billed $11,200 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 69) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.
47 generic and 22 brand-name prescriptions · $11,200 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Breo Ellipta | 13 | $7,800 | $600 |
| Montelukast | 14 | $305 | $22 |
Year by year
| 2024 | 69 | 44 | 0% (0) | 32% | $11,200 |
| 2023 | 254 | 127 | 0% (0) | 34% | $43,062 |
| 2022 | 257 | 126 | 0% (0) | 36% | $48,386 |
| 2021 | 498 | 151 | 0% (0) | 40% | $99,492 |
| 2020 | 687 | 199 | 0% (0) | 38% | $109,817 |
| 2019 | 1,097 | 266 | 0% (0) | 34% | $129,137 |
| 2018 | 803 | 210 | 0% (0) | 34% | $97,795 |
| 2017 | 594 | 165 | 0% (0) | 35% | $63,070 |
| 2016 | 417 | 123 | None | 43% | $55,153 |
| 2015 | 484 | 152 | 0% (0) | 46% | $55,618 |
| 2014 | 378 | 123 | None | None | $38,800 |
| 2013 | 445 | 103 | None | None | $48,038 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Breo Ellipta | 26 | $15,319 | $589 |
| Symbicort | 18 | $7,633 | $424 |
| Azelastine | 23 | $1,210 | $53 |
| Fluticasone Propionate | 51 | $1,059 | $21 |
| Montelukast | 37 | $863 | $23 |
| Albuterol Sulfate Hfa | 11 | $464 | $42 |
2022: 9 drugs
| Breo Ellipta | 20 | $12,284 | $614 |
| Trelegy Ellipta | 12 | $10,279 | $857 |
| Symbicort | 15 | $6,078 | $405 |
| Azelastine | 33 | $1,424 | $43 |
| Ipratropium | 11 | $730 | $66 |
| Albuterol Sulfate Hfa | 14 | $479 | $34 |
| Fluticasone Propionate | 30 | $367 | $12 |
| Montelukast | 22 | $351 | $16 |
| Azithromycin | 21 | $130 | $6 |
2021: 14 drugs
| Breo Ellipta | 43 | $26,804 | $623 |
| Trelegy Ellipta | 24 | $17,513 | $730 |
| Symbicort | 24 | $10,826 | $451 |
| Spiriva Respimat | 13 | $8,944 | $688 |
| Wixela Inhub | 12 | $3,776 | $315 |
| Azelastine | 67 | $3,056 | $46 |
| Arnuity Ellipta | 14 | $2,980 | $213 |
| Albuterol Sulfate Hfa | 41 | $1,687 | $41 |
| Fluticasone-Salmeterol | 13 | $1,394 | $107 |
| Fluticasone Propionate | 77 | $1,197 | $16 |
| Montelukast | 36 | $788 | $22 |
| Ipratropium | 11 | $672 | $61 |
| Levocetirizine Dihydrochloride | 18 | $291 | $16 |
| Prednisone | 18 | $41 | $2 |
2020: 16 drugs
| Breo Ellipta | 39 | $20,751 | $532 |
| Symbicort | 38 | $17,743 | $467 |
| Spiriva Respimat | 28 | $15,427 | $551 |
| Flovent Hfa | 20 | $9,427 | $471 |
| Advair Hfa | 12 | $8,748 | $729 |
| Azelastine | 98 | $4,831 | $49 |
| Arnuity Ellipta | 12 | $4,338 | $361 |
| Fluticasone Propionate | 105 | $1,806 | $17 |
| Ventolin Hfa | 27 | $1,539 | $57 |
| Montelukast | 99 | $1,499 | $15 |
| Albuterol Sulfate Hfa | 28 | $1,393 | $50 |
| Ipratropium | 13 | $604 | $46 |
| Levocetirizine Dihydrochloride | 15 | $374 | $25 |
| Amoxicillin-Clavulanate Potass | 11 | $150 | $14 |
| Azithromycin | 16 | $114 | $7 |
| Prednisone | 25 | $72 | $3 |
2019: 20 drugs
| Symbicort | 60 | $25,175 | $420 |
| Breo Ellipta | 53 | $23,298 | $440 |
| Spiriva Respimat | 36 | $15,992 | $444 |
| Advair Diskus | 24 | $9,767 | $407 |
| Advair Hfa | 22 | $9,458 | $430 |
| Azelastine | 157 | $6,561 | $42 |
| Flovent Hfa | 25 | $6,224 | $249 |
| Ventolin Hfa | 56 | $3,256 | $58 |
| Wixela Inhub | 14 | $3,103 | $222 |
| Fluticasone Propionate | 191 | $2,827 | $15 |
| Ipratropium | 28 | $1,620 | $58 |
| Montelukast | 99 | $1,247 | $13 |
| Proair Hfa | 18 | $1,171 | $65 |
| Levocetirizine Dihydrochloride | 26 | $920 | $35 |
| Albuterol Sulfate Hfa | 11 | $512 | $47 |
| Amoxicillin-Clavulanate Potass | 20 | $324 | $16 |
| Azithromycin | 32 | $250 | $8 |
| Triamcinolone Acetonide | 17 | $165 | $10 |
| Prednisone | 62 | $139 | $2 |
| Hydroxyzine | 11 | $57 | $5 |
2018: 17 drugs
| Breo Ellipta | 56 | $25,020 | $447 |
| Symbicort | 31 | $14,293 | $461 |
| Advair Hfa | 20 | $10,893 | $545 |
| Advair Diskus | 17 | $9,614 | $566 |
| Azelastine | 113 | $4,723 | $42 |
| Flovent Hfa | 13 | $2,952 | $227 |
| Ventolin Hfa | 40 | $2,218 | $55 |
| Fluticasone Propionate | 140 | $2,058 | $15 |
| Proair Hfa | 24 | $1,472 | $61 |
| Montelukast | 103 | $1,118 | $11 |
| Ipratropium | 20 | $992 | $50 |
| Olopatadine | 17 | $880 | $52 |
| Levocetirizine Dihydrochloride | 25 | $691 | $28 |
| Azithromycin | 24 | $208 | $9 |
| Triamcinolone Acetonide | 11 | $180 | $16 |
| Amoxicillin-Clavulanate Potass | 16 | $179 | $11 |
| Prednisone | 38 | $129 | $3 |
2017: 11 drugs
| Advair Hfa | 28 | $15,604 | $557 |
| Advair Diskus | 17 | $7,343 | $432 |
| Symbicort | 21 | $6,263 | $298 |
| Breo Ellipta | 12 | $5,172 | $431 |
| Azelastine | 72 | $3,512 | $49 |
| Fluticasone Propionate | 127 | $1,797 | $14 |
| Ventolin Hfa | 27 | $1,447 | $54 |
| Levocetirizine Dihydrochloride | 27 | $869 | $32 |
| Montelukast | 89 | $849 | $10 |
| Ipratropium | 19 | $833 | $44 |
| Prednisone | 19 | $50 | $3 |
2016: 13 drugs
| Advair Hfa | 21 | $11,528 | $549 |
| Symbicort | 23 | $7,176 | $312 |
| Advair Diskus | 16 | $5,926 | $370 |
| Nasonex | 12 | $2,860 | $238 |
| Azelastine | 47 | $2,415 | $51 |
| Proair Hfa | 25 | $1,398 | $56 |
| Fluticasone Propionate | 79 | $1,215 | $15 |
| Ventolin Hfa | 16 | $829 | $52 |
| Ipratropium | 13 | $582 | $45 |
| Montelukast | 37 | $479 | $13 |
| Levocetirizine Dihydrochloride | 15 | $369 | $25 |
| Azithromycin | 15 | $95 | $6 |
| Prednisone | 14 | $46 | $3 |
2015: 12 drugs
| Symbicort | 21 | $8,906 | $424 |
| Advair Hfa | 25 | $7,912 | $316 |
| Qvar | 33 | $6,780 | $205 |
| Advair Diskus | 20 | $6,418 | $321 |
| Azelastine | 32 | $2,227 | $70 |
| Proair Hfa | 33 | $1,704 | $52 |
| Fluticasone Propionate | 92 | $1,178 | $13 |
| Montelukast | 51 | $884 | $17 |
| Ventolin Hfa | 11 | $653 | $59 |
| Ipratropium | 23 | $609 | $26 |
| Azithromycin | 14 | $103 | $7 |
| Prednisone | 15 | $42 | $3 |
2014: 11 drugs
| Advair Diskus | 22 | $7,150 | $325 |
| Spiriva | 16 | $4,576 | $286 |
| Qvar | 14 | $2,853 | $204 |
| Nasonex | 13 | $2,154 | $166 |
| Azelastine | 27 | $1,591 | $59 |
| Montelukast | 53 | $1,317 | $25 |
| Fluticasone Propionate | 59 | $1,124 | $19 |
| Proair Hfa | 21 | $1,031 | $49 |
| Ventolin Hfa | 11 | $488 | $44 |
| Ipratropium | 16 | $442 | $28 |
| Azithromycin | 12 | $110 | $9 |
2013: 9 drugs
| Advair Diskus | 35 | $11,669 | $333 |
| Spiriva | 35 | $10,313 | $295 |
| Symbicort | 13 | $3,618 | $278 |
| Montelukast | 92 | $2,626 | $29 |
| Fluticasone Propionate | 57 | $1,687 | $30 |
| Proair Hfa | 27 | $1,263 | $47 |
| Ventolin Hfa | 17 | $956 | $56 |
| Ipratropium | 13 | $306 | $24 |
| Alendronate | 20 | $166 | $8 |
Money from drug and device companies
$192 in 2023
| 2023 | 3 | 3 | None | $192 |
| 2022 | 6 | 7 | None | $161 |
| 2021 | 1 | 1 | None | $13 |
| 2020 | 5 | 19 | None | $634 |
| 2019 | 11 | 15 | None | $557 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Farxiga | $110 | 1 payment
|
| Incyte | Opzelura | $55 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $26 | 1 payment
|
See all 3 published payments
| Incyte | Meals · 2023-11-11 | Opzelura | $55 |
| AstraZeneca Pharmaceuticals LP | Meals · 2023-06-02 | Farxiga | $110 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2023-01-24 | Takhzyro | $26 |
See earlier years (2022, 2021, 2020, 2019)
2022: $161
| Greer Laboratories | Oralair | $42 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $33 | 1 payment
|
| GlaxoSmithKline | Nucala | $23 | 1 payment
|
| Pharming Healthcare | Ruconest | $23 | 1 payment
|
| BioCryst US Sales Co. | Orladeyo | $21 | 1 payment
|
| Covis Pharma GmBH | Alvesco | $18 | 1 payment
|
2021: $13
| GlaxoSmithKline | Trelegy Ellipta | $13 | 1 payment
|
2020: $634
| Octapharma USA | Cutaquig | $167 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $157 | 3 payments
|
| CSL Behring | Haegarda | $155 | 2 payments
|
| GlaxoSmithKline | Nucala | $115 | 6 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $40 | 2 payments
|
2019: $557
| Regeneron Healthcare Solutions | Dupixent | $138 | 2 payments
|
| Jazz Pharmaceuticals | Xyrem | $100 | 1 payment
|
| Shire North American Group | Hyqvia | $92 | 2 payments
|
| Octapharma USA | Cutaquig | $57 | 1 payment
|
| GlaxoSmithKline | Nucala | $41 | 2 payments
|
| Genentech USA | Xolair | $37 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $21 | 1 payment
|
| Genzyme | Dupixent | $21 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $20 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Altreno | $19 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1114923307
- Licence
- CA A35393California A35393: Current · expires 2028-03-31
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 1114923307, CA GR0043790
- Taxonomy
- Federal specialty code 207KA0200X (207KA0200X); Pediatrics (208000000X)
- Mailing address
- 7471 N Fresno St, Fresno, CA, 93720
- NPI first listed
- 2005-06-22
- NPI last updated
- 2016-04-25
This is when the NPI record was last certified, not a medical board exam.